Increased Levels of Soluble CD206 Associated with Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis

被引:13
作者
Shen, Ya-Wen [1 ,2 ]
Zhang, Ya-Mei [2 ]
Huang, Zhen-Guo [3 ]
Wang, Guo-Chun [1 ,2 ]
Peng, Qing-Lin [1 ,2 ]
机构
[1] Peking Univ, China Japan Friendship Sch Clin Med, Beijing 100029, Peoples R China
[2] China Japan Friendship Hosp, Beijing Key Lab Immune Mediated Inflammatory Dis, Dept Rheumatol, Beijing 100029, Peoples R China
[3] China Japan Friendship Hosp, Dept Radiol, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
IDIOPATHIC INFLAMMATORY MYOPATHIES; PREDICTIVE FACTORS; MACROPHAGE ACTIVATION; MANNOSE RECEPTOR; GENE; 5; POLYMYOSITIS; AUTOANTIBODIES; MYOSITIS; MARKERS; MUSCLE;
D O I
10.1155/2020/7948095
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objective. Soluble CD206 (sCD206) is considered a macrophage activation marker, and a previous study proved it as a potential biomarker to predict the severity of anti-melanoma differentiation-associated gene 5- (anti-MDA-5-) positive dermatomyositis- (DM-) associated interstitial lung disease (ILD). To investigate the role of sCD206 in various subtypes of DM, we evaluated the serum level of sCD206 in patients with different myositis-specific autoantibodies besides anti-MDA-5 and clarified its clinical significance. Methods. Commercial enzyme-linked immunosorbent assay kits were used to detect serum concentrations of sCD206 in 150 patients with DM and 52 healthy controls (HCs). Correlations between sCD206 levels and clinical features, laboratory examinations, and pulmonary function test parameters were analysed. Results. The median concentrations of serum sCD206 in DM patients were significantly higher than those in HCs (p0.0001). Furthermore, median sCD206 levels were elevated in patients with ILD (p=0.001), especially in those with rapidly progressive ILD (RP-ILD) (p0.0001). In addition, sCD206 levels were negatively correlated with the pulmonary function test results, including the percent predicted forced vital capacity (r=-0.234, p=0.023), percent predicted forced expiratory volume in one second (r=-0.225, p=0.030), and percent predicted carbon monoxide diffusion capacity (r=-0.261, p=0.014). Age- and gender-adjusted multivariable analysis showed that sCD206 was an independent prognostic factor for RP-ILD in patients with DM. A longitudinal study showed that sCD206 levels were positively correlated with the physician global assessment visual analog scale scores (beta=54.201, p=0.001). Conclusion. Serum sCD206 levels were significantly increased in patients with DM and significantly associated with RP-ILD, suggesting that sCD206 is an important biological predictor of RP-ILD in patients with DM.
引用
收藏
页数:11
相关论文
共 46 条
[1]  
Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646
[2]   POLYMYOSITIS AND DERMATOMYOSITIS .2. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (08) :403-407
[3]   POLYMYOSITIS AND DERMATOMYOSITIS .1. [J].
BOHAN, A ;
PETER, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (07) :344-347
[4]   Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group [J].
Cavagna, Lorenzo ;
Nuno, Laura ;
Scire, Carlo Alberto ;
Govoni, Marcello ;
Lopez Longo, Francisco Javier ;
Franceschini, Franco ;
Neri, Rossella ;
Castaneda, Santos ;
Sifuentes Giraldo, Walter Alberto ;
Caporali, Roberto ;
Iannone, Florenzo ;
Fusaro, Enrico ;
Paolazzi, Giuseppe ;
Pellerito, Raffaele ;
Schwarting, Andreas ;
Saketkoo, Lesley Ann ;
Ortego-Centeno, Norberto ;
Quartuccio, Luca ;
Bartoloni, Elena ;
Specker, Christof ;
Pina Murcia, Trinitario ;
La Corte, Renato ;
Furini, Federica ;
Foschi, Valentina ;
Bachiller Corral, Javier ;
Airo, Paolo ;
Cavazzana, Ilaria ;
Martinez-Barrio, Julia ;
Hinojosa, Michelle ;
Giannini, Margherita ;
Barsotti, Simone ;
Menke, Julia ;
Triantafyllias, Kostantinos ;
Vitetta, Rosetta ;
Russo, Alessandra ;
Bogliolo, Laura ;
Bajocchi, Gianluigi ;
Bravi, Elena ;
Barausse, Giovanni ;
Bortolotti, Roberto ;
Selmi, Carlo ;
Parisi, Simone ;
Salaffi, Fausto ;
Montecucco, Carlomaurizio ;
Angel Gonzalez-Gay, Miguel .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2017, 52 (01) :71-80
[5]   Interstitial Lung Disease Associated With the Idiopathic Inflammatory Myopathies What Progress Has Been Made in the Past 35 Years? [J].
Connors, Geoffrey R. ;
Christopher-Stine, Lisa ;
Oddis, Chester V. ;
Danoff, Sonye K. .
CHEST, 2010, 138 (06) :1464-1474
[6]   Inflammatory Muscle Diseases [J].
Dalakas, Marinos C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18) :1734-1747
[7]   Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease [J].
Enomoto, Yasunori ;
Suzuki, Yuzo ;
Hozumi, Hironao ;
Mori, Kazutaka ;
Kono, Masato ;
Karayama, Masato ;
Furuhashi, Kazuki ;
Fujisawa, Tomoyuki ;
Enomoto, Noriyuki ;
Nakamura, Yutaro ;
Inui, Naoki ;
Suzuki, Daisuke ;
Ogawa, Noriyoshi ;
Nakashima, Ran ;
Mimori, Tsuneyo ;
Iwashita, Toshihide ;
Suda, Takafumi .
ARTHRITIS RESEARCH & THERAPY, 2017, 19
[8]  
Fujisawa T, 2017, RESPIR INVESTIG, V55, P130, DOI 10.1016/j.resinv.2016.09.006
[9]   Influence of the mannose receptor in host immune responses [J].
Gazi, Umut ;
Martinez-Pomares, Luisa .
IMMUNOBIOLOGY, 2009, 214 (07) :554-561
[10]   Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis [J].
Gono, Takahisa ;
Sato, Shinji ;
Kawaguchi, Yasushi ;
Kuwana, Masataka ;
Hanaoka, Masanori ;
Katsumata, Yasuhiro ;
Takagi, Kae ;
Baba, Sayumi ;
Okamoto, Yuko ;
Ota, Yuko ;
Yamanaka, Hisashi .
RHEUMATOLOGY, 2012, 51 (09) :1563-1570